Ms. Wright joined Jaguar’s team in December 2015. She brings more than 30 years of financial experience with a number of international biotech companies. Prior to joining Jaguar Animal Health, Ms. Wright most recently was head of finance for Clene Nanomedicine. She also served as vice president of finance and corporate controller at multiple other private and public companies, including Veracyte and Intermune, which was acquired by Roche. Early in her career, Ms. Wright spent 13 years at Genentech building a strong foundation in the biotech industry. Ms. Wright has been responsible for financial reporting and operational financial planning and analysis, including R&D, clinical, marketing and sales, G&A and manufacturing; as well as tax and treasury planning. She has participated in three IPOs and numerous offerings. Ms. Wright holds a BS in Accounting and Marketing from the University of California Walter A. Haas School Of Business. Ms. Wright joined Jaguar’s team in December 2015. She brings more than 30 years of financial experience with a number of international biotech companies. Prior to joining Jaguar Animal Health, Ms. Wright most recently was head of finance for Clene Nanomedicine. She also served as vice president of finance and corporate controller at multiple other private and public companies, including Veracyte and Intermune, which was acquired by Roche. Early in her career, Ms. Wright spent 13 years at Genentech building a strong foundation in the biotech industry. Ms. Wright has been responsible for financial reporting and operational financial planning and analysis, including R&D, clinical, marketing and sales, G&A and manufacturing; as well as tax and treasury planning. She has participated in three IPOs and numerous offerings. Ms. Wright holds a BS in Accounting and Marketing from the University of California Walter A. Haas School Of Business.

General Science